Zhuoxian Cao

Attenuation of NLRP3 Inflammasome Activation by Indirubin-Derived PROTAC Targeting HDAC6.

Hening Lin, Ting Liu, Yongjun Li, 2021, ACS chemical biology.

Unexpected small molecules as novel SIRT2 suicide inhibitors.

Zhuoxian Cao, Jie Wang, Yonglong Zhao, 2020, Bioorganic & medicinal chemistry.

Development of a mitochondrial sirtuin 4 FRET assay based on its activity for removing 3-hydroxy-3-methylglutaryl (HMG) modification

Yonglong Zhao, Yongjun Li, Zhuoxian Cao, 2021, RSC advances.

Direct C(sp3)–H acyloxylation of indolin-3-ones with carboxylic acids catalysed by KI

Fen Yang, Meng Zhou, Yong Tang, 2020 .

A Series of Novel HDAC Inhibitors with Anthraquinone as a Cap Group.

Zhuoxian Cao, Jie Wang, Yonglong Zhao, 2020, Chemical & pharmaceutical bulletin.

SIRT3‐dependent delactylation of cyclin E2 prevents hepatocellular carcinoma growth

Xiaohu Zheng, Haiming Wei, W. Ding, 2023, EMBO reports.

Indirubin Derivatives as Dual Inhibitors Targeting Cyclin-Dependent Kinase and Histone Deacetylase for Treating Cancer.

Hening Lin, Ting Liu, Yongjun Li, 2021, Journal of medicinal chemistry.

Cysteine derivatives as acetyl lysine mimics to inhibit zinc-dependent histone deacetylases for treating cancer.

Hening Lin, Ting Liu, Yongjun Li, 2021, European journal of medicinal chemistry.